[HTML][HTML] ApoE lipidation as a therapeutic target in Alzheimer's disease

MF Lanfranco, CA Ng, GW Rebeck - International journal of molecular …, 2020 - mdpi.com
Apolipoprotein E (APOE) is the major cholesterol carrier in the brain, affecting various
normal cellular processes including neuronal growth, repair and remodeling of membranes …

[HTML][HTML] APOE and Alzheimer's disease: from lipid transport to physiopathology and therapeutics

MA Husain, B Laurent, M Plourde - Frontiers in neuroscience, 2021 - frontiersin.org
Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by
extracellular amyloid β (Aβ) and intraneuronal tau protein aggregations. One risk factor for …

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Y Yamazaki, N Zhao, TR Caulfield, CC Liu… - Nature Reviews …, 2019 - nature.com
Polymorphism in the apolipoprotein E (APOE) gene is a major genetic risk determinant of
late-onset Alzheimer disease (AD), with the APOE* ε 4 allele conferring an increased risk …

[HTML][HTML] ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies

AC Raulin, SV Doss, ZA Trottier, TC Ikezu, G Bu… - Molecular …, 2022 - Springer
Alzheimer's disease (AD) is the most common cause of dementia worldwide, and its
prevalence is rapidly increasing due to extended lifespans. Among the increasing number of …

[HTML][HTML] Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease

T Williams, DR Borchelt, P Chakrabarty - Molecular neurodegeneration, 2020 - Springer
One of the primary genetic risk factors for Alzheimer's disease (AD) is the presence of the Ɛ4
allele of apolipoprotein E (APOE). APOE is a polymorphic lipoprotein that is a major …

Genetic restoration of plasma ApoE improves cognition and partially restores synaptic defects in ApoE-deficient mice

C Lane-Donovan, WM Wong… - Journal of …, 2016 - Soc Neuroscience
Alzheimer's disease (AD) is the most common form of dementia in individuals over the age
of 65 years. The most prevalent genetic risk factor for AD is the ε4 allele of apolipoprotein E …

Apolipoprotein E as a therapeutic target in Alzheimer's disease: a review of basic research and clinical evidence

Y Yamazaki, MM Painter, G Bu, T Kanekiyo - CNS drugs, 2016 - Springer
Alzheimer's disease (AD) is a devastating neurodegenerative disorder that causes
progressive cognitive decline. The majority of AD cases are sporadic and late-onset (> 65 …

[HTML][HTML] APOE targeting strategy in Alzheimer's disease: lessons learned from protective variants

G Bu - Molecular neurodegeneration, 2022 - Springer
The APOE gene is the strongest genetic risk factor for Alzheimer's disease (AD) with the ε4
allele increasing the risk by 2-4 folds compared to the most common ε3 allele [1]. The high …

Role of apolipoprotein E in neurodegenerative diseases

VV Giau, E Bagyinszky, SSA An… - … disease and treatment, 2015 - Taylor & Francis
Apolipoprotein E (APOE) is a lipid-transport protein abundantly expressed in most neurons
in the central nervous system. APOE-dependent alterations of the endocytic pathway can …

Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease

Y Huang - Trends in molecular medicine, 2010 - cell.com
Human apolipoprotein (APO) E has three common isoforms that differentially affect lipid and
neuronal homeostasis. APOE4, the major known genetic risk factor for Alzheimer's disease …